The rise of a polarizing mRNA scientist turned skeptic

Just over two years ago, Robert Malone was living a relatively quiet life on his...
Read on Insider.com
INSIDER
Subscribe

INSIDER FEATURED ARTICLE

Insider Featured Article

SCIENCE

Inside The rise of Robert Malone, the mRNA scientist turned vaccine skeptic who shot to fame on Joe Rogan's podcast

By Hilary Brueck


Just over two years ago, Robert Malone was living a relatively quiet life on his Virginia farm, training and breeding Portuguese horses with his wife, Jill.

But once the novel coronavirus was discovered and sequenced in Wuhan, China, everything changed, nearly overnight. Within days, mRNA coronavirus vaccines were being widely acknowledged as one of our best bets against the virus. Scientists started using the technology to develop shots — on a breathtakingly rapid timeline.

Suddenly, it seemed, everyone wanted to know who was responsible for this promising technique.

Flattering high-profile features and deep dives were written about Katalin Karikó and her University of Pennsylvania colleague Drew Weissman, some of the first scientists who figured out how to properly modify mRNA to get it into human cells more than 15 years ago. Ugur Sahin and Özlem Türeci, the founders of the German biotech company BioNTech, also made the news for using that same technique to develop a coronavirus vaccine in partnership with the pharmaceutical giant Pfizer.

Malone felt slighted. He wasn't getting any credit for his decades-old role in these new vaccines. What about all the initial work he did successfully injecting mRNA into mice for the very first time in the late 1980s? He began to attempt to set the record straight.

And people listened. Malone has become a regular on Fox News and spent three hours on Joe Rogan's podcast in late December. He's become a trusted source for people everywhere who aren't quite sure about these mRNA vaccines or whether they are really safe. Rising to the crowd's call for an indictment of the COVID-19 vaccines from Pfizer and Moderna, Malone has seemingly become more polarized by the day. Recently, Malone publicly vilified and threatened legal action against another physician who reported his vaccine misinformation campaign to the Maryland Board of Physicians, and accused the Centers for Disease Control and Prevention of scientific fraud.

After getting kicked off Twitter in December for sharing some misleading interpretations of Pfizer's trial data, he's now largely confined to the extremist margins of the internet and society, where, fired up by the applause he receives, he's become a valuable resource to anyone who may want a reasonable person to tell them why, exactly, to be skeptical of the COVID-19 vaccines.

There are reasons people are listening to Malone — he's an expert source, and he's asking interesting questions about the vaccines

Insider Featured Article

Malone isn't the raving propagandist that some might like to dismiss him as — one who's wrong about everything that comes out of his mouth. As easy as it can feel for a vaccinated person to say he's full of it and lying about everything related to mRNA technology, the real story is far from that simple.

The mRNA vaccines we have are working to keep people from dying and staving off severe disease in many, many hundreds of millions of people around the world, but they're not perfect. They don't stop all infections, and it does seem like the immune protection they offer may fade more quickly than many would've hoped, especially now that new variants are at play.

They don't promise to stop all transmission (but it's worth mentioning that vaccinated people recover more quickly and easily from COVID-19, avoiding more severe disease themselves, lowering their viral loads, and making them less of a threat to their neighbors more quickly too). What's more, some people do have severe, painful, and rare vaccine side effects. While those are largely temporary, we don't totally understand why they are triggered in some people and not others.

Malone has thrived in this space of the sometimes unanswerable and often complicated, frustrating lingering questions of the pandemic. He's become an icon and a friend to people who feel not only left out and dismissed by the scientific community but also ignored and shamed by their exhausted vaccinated friends, colleagues, and family with the dismissive attitude of, "Get vaccinated already, morons, and stop questioning any of this." He's created a comfortable home base for those who feel just as disenfranchised as he does, and there's a reason they're listening to him.

Left out of the Nobel buzz

Insider Featured Article

Malone is known in his field, and his work is often cited by the many, many others who've followed him to work further on mRNA vaccines and therapeutics. However, Malone is but one of a great many scientists who've made today's mRNA vaccines possible.

What he did, in a nutshell, was show that messenger RNA — a notoriously unstable and hard-to-work-with single-stranded molecule — could be injected into mammals by using a lipid nanoparticle (a glob of fat, basically) as its package. He worked on that ground-laying research in the late '80s with scientists such as Philip Felgner, who is considered a contender for the Nobel Prize and who won Spain's equivalent last year (The Princess of Asturias Award).

"There are many, many contributors to the field, and it's really hard to distinguish and determine who brought more," Ingmar Hoerr, the founder of the German biotechnology company CureVac, told Insider.

Pierre Meulien, a molecular biologist who runs the European Union's Innovative Medicines Initiative, said that in 1993 he and his team were the first "to demonstrate that you could induce an immune response with mRNA." But, like Malone's experiments before, that research was in mice only.

"I don't think there is one inventor of mRNA vaccines," Meulien said. "It's how science works. I mean, you add up the number of people who've published in this area over the last 30 years — it is hundreds and hundreds of people."

It wasn't until more than 10 years after Meulien that Hoerr injected "the first human beings ever worldwide with RNA" in 2005, he said. At the time, many scientists hoped mRNA would be a great help for cancer treatment, and Hoerr was just one of them.

Matthew Winkler, a geneticist and biotech entrepreneur, was also hoping to develop mRNA therapeutics to kill tumors when he started Mirna Therapeutics in 2007. "We were delivering micro RNAs into humans for therapeutic purposes," Winkler said. "These are the clear antecedents to delivering mRNAs as a vaccine."

By that point, Malone had long moved away from the field of mRNA vaccine development. More recently, he authored papers on how to combat Zika and accelerate DNA-vaccine development.

At the outset of the pandemic, he offered some initial ideas about what doctors might take off the shelf to help treat COVID-19. He was part of a research group that won a $21 million emergency contract from the Trump administration to study famotidine (brand name, Pepcid AC) as a coronavirus therapeutic. It's still unclear whether famotidine does much for COVID-19 patients. Some very small, low-powered studies suggest it could help decrease inflammation and marginally speed recovery.

According to Science Magazine, Malone was also part of a classified US government project called DOMANE, which used artificial intelligence and computer simulations to identify existing drugs that might be successfully repurposed "against threats such as new viruses."

An attempt to set the record straight began morphing into an anti-vaccine crusade

Insider Featured Article

Malone is fully vaccinated — he got both shots of Moderna's COVID-19 vaccine in spring last year after it was authorized by the FDA in December 2020.

He was hoping getting jabbed might help with some of the long-COVID-19 symptoms he was having at the time, but it didn't. Scattered anecdotal media reports were suggesting that promise at the time, but the idea has largely faded as more people have gotten vaccinated and more time has elapsed since their jabs.

Dr. Bruce Patterson, who runs a long-COVID-19 treatment center, said at a conference this month that many of his long-COVID-19 patients "who got better, after a week or two, reverted back to where they were."

Malone said the side effects from his first shot were nothing remarkable, but after his second, he started complaining of high blood pressure , saying he'd been given a "bad batch," and raising unfounded concerns that the usual protocols weren't being followed at the Food and Drug Administration — the federal agency that's meant to view new drugs, treatments, and vaccines as "guilty until proven innocent," as he often says.

It's true that vaccination isn't one-size-fits-all. Different immune systems will react differently to vaccines and likely benefit from different COVID-19-vaccine regimens in the future, an immunological truth that everyone from Dr. Anthony Fauci to Malone agrees on. It's also possible that Malone didn't need a second shot since he'd already had COVID-19.

But to imply the FDA hasn't taken all the appropriate safety measures for these vaccines — simply because people may react differently to getting immunized or experience other issues around the time of their vaccination that may or may not have anything to do with the shot itself — is misleading fearmongering. Both the CDC and the FDA keep an eye out for discrepancies in vaccine-batch quality, and no recalls have been issued in the US for a COVID-19 vaccine.

"Following vaccination, after an immune response is triggered, the body breaks down the components of the vaccine and eliminates them in approximately 36 hours after vaccination," an FDA representative told Insider.

Further, both the FDA and the CDC monitor the safety of all vaccines all the time, in two key ways. First, federal regulators keep tabs on the Vaccine Adverse Event Reporting System, which gathers reports from both citizens and healthcare workers nationwide of anything amiss after a vaccination — whether it is directly related to vaccination or not. Second, the FDA and the CDC also review large, population-based healthcare datasets, to round out the picture of what happens after people get vaccinated with a more active form of surveillance. These are both strategies that Malone is well aware of, given his career trajectory.

Malone has a pretty good grasp on how the US regulatory systems for vaccines operate, having worked in California's biotech industry, as well as on government contracts and scientific review boards for many years. He calls out Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research, by name, saying they've spoken about COVID-19-vaccine safety before. (When asked whether Marks had indeed spoken with Malone, an FDA representative told Insider: "We cannot comment on or confirm any non-public meetings.")

The Rogan effect catapulted Malone further into fame and controversy

Insider Featured Article

Malone's celebrity as a vocal vaccine opponent, already many months in the making, skyrocketed to stratospheric proportions in December — thanks to Rogan, the former "Fear Factor" host who's become one of the most popular podcasters.

Rogan's podcasting strategy is unabashedly ill-informed.

"Oftentimes, I have no idea what I'm going to talk about until I sit down and talk to people," he said recently.

This means people like Malone and Dr. Pierre Kory have come on his show and remained largely unchallenged as they touted unproven COVID-19 treatments and said the vaccines aren't safe — without providing context or evidence. (Kory is one of the most prominent voices advocating more ivermectin prescriptions.)

On December 29, Malone was suspended from Twitter after saying that people who got Pfizer's vaccine were getting sicker than those who didn't. (They weren't. A small number of study participants in both the vaccine trial group and the placebo group — i.e. people in the trial who did not receive the vaccine — got sick with other illnesses, which happens when you're studying more than 40,000 people over a period of several months. Importantly, those non-COVID disease and death rates were not markedly different among the vaccinated versus unvaccinated cohorts in the study.) On December 30, Malone recorded a podcast with Rogan, and on December 31, their three-hour interview aired on Spotify, where Malone railed against some kind of "mass formation psychosis" driving people to worry too much about COVID-19.

Malone has also become a regular on Fox News, even as he's described the experience as "a little weird."

"Right now, conservative media are the ones that are open," he told TrialSiteNews, where he's a member of the advisory committee, last year.

He's moved to the social-media platform Gettr — an alternative to Twitter founded by a former Trump aide — and become more prolific and political on his lucrative Substack. He speaks to large crowds of cheering fans, as he did most notably this year at a January 23 "Defeat the Mandates: An American Homecoming" rally on the National Mall in Washington, DC.

"Regarding the genetic COVID vaccines, the science is settled: They're not working," he told the crowd. "Whether they made sense for protecting our elderly and frail from the original virus is irrelevant."

With a new, more infectious variant on the scene, and the far right embracing his guidance far more than the scientific community ever will, he's turned from a vocal asker of vaccine questions to an outright vaccine-opposing evangelical, seemingly ignoring any and all evidence of vaccine safety.

Malone has found good company lately in the ivermectin-promoting Front Line COVID-19 Critical Care Alliance (of which Kory is a leading member), whose off-kilter COVID-19 treatment guidance he touts in an autoreply to anyone who emails him.

"As a scientist and clinical trial specialist, I do not see patients and do not prescribe drugs," Malone says in his autogenerated email response. "If you are searching for a physician, I suggest going to the FLCCC website to see if anyone from that organization can help you."

Malone told Tucker Carlson in an interview last month that it was "unfortunate" US military personnel, among other employees, were being "forced to take these products, while they're still experimental." (Both Moderna's and Pfizer's vaccines are fully approved for adults by the FDA, and the military has a long history of requiring many vaccines to protect US forces from disease.)

Malone's concerns, from unfounded to impossible to refute

Despite Malone's qualifications and industry expertise, many of his loudest concerns about these vaccines are off base. When he says the vaccines can permeate the blood-brain barrier, or that the tiny fatty particles they're packaged inside might hang around in women's ovaries, those are gross misinterpretations of how these vaccines work. They sound scary but aren't grounded in good evidence.

There will always be hypothetical "what ifs" for any new drug, vaccine, or treatment. But Malone's concerns are not ones that have other mRNA scientists worried. Take Andrew Geall, who developed some of the first lipid nanoparticles for mRNA vaccines.

"There was a pandemic. You need to do something — there's no doubt the right thing was done," Geall said. That's why his entire family is vaccinated.

Still, vaccine research and development doesn't end with the first doses in arms. Scientists are still studying the vaccines to improve them. Already, Canadian researchers have learned that spacing out the first and second doses of mRNA vaccines, to more than one month apart, can help prevent more cases of myocarditis in teens and young adults and improve the body's immune response at the same time, a win-win for vaccination safety and efficacy — one that the CDC adopted last week, to the applause of many US experts.

However, the truth is there is a lot we already know about these vaccines, safetywise.

That data isn't just being collected by American regulators at the FDA and the CDC. There's also mandatory pharmacovigilance in the European Union, Japan has its own regulatory agency, and there are many other vaccine-surveillance systems in place in nations and hospitals around the world. None have raised major issues about the mRNA vaccines for COVID-19.

"It's not as if there hasn't been a huge amount of safety data on millions and millions of people," Meulien said. "In order to find those very, very, very rare events, you have to look at safety data on absolutely millions of people — and this has been done. So I don't think we can turn around and say these vaccines aren't safe. I think they are safe."

The idea that a terrifying, mysterious safety signal we haven't seen yet might surface years from now is not only highly unlikely, it has never happened with any vaccine, because that is not how vaccines work. Vaccine side effects, and human immune responses to vaccines, surface in minutes, hours, days, weeks, or, sometimes, months — not years.

Take messenger RNA. It does not hang around in the body for a long time. At most, it's detectable for a few days. The injected mRNA tells your body to make a viral protein to teach the immune system how to fight the coronavirus. That protein, in turn, hangs around for about a week of viral boot camp.

"Nature made a messenger. It's called messenger RNA," Hoerr, CureVac's founder, said, expressing the transient nature of this molecule, which only instructs the body in what to do to fight the coronavirus. "It's an ideal molecule to work on in terms of therapies and drugs' development."

Scientists agree with Malone on one thing

Insider Featured Article

Certainly, today's COVID-19 vaccines can and will be improved. Vaccine makers will likely do more to refine the vaccines' lipid nanoparticle (vaccine package) in coming years, with the goals of lessening side effects, improving the performance of the vaccines against future variants, and stepping up how long vaccine protection lasts (an especially critical issue for older people).

It is also possible, likely even, that getting infected with the virus may give people better immunity than getting vaccinated, as Malone has suggested.

Geall calls getting infected the equivalent of "a booster against all 26 proteins in the virus," instead of a single antigen. But, of course, the risks of infection are still far greater than the risks of vaccination, no matter who you are, how vulnerable, or how old. (And the hybrid immunity afforded by vaccination and infection may turn out to be the best kind of immunity you can get.)

If Malone is right about one thing pertaining to the mRNA vaccines, Geall said, it's that it is still important to keep researching these products and answering any yet unanswered questions about them, in addition to improving how and when they're used.

"Would I have preferred that there had been 15 years of research and safety generation through clinical trials? Absolutely," Geall said. "But that wasn't an option during the pandemic."

So he, and all the other scientists interviewed for this article, got vaccinated with the mRNA vaccines that they, Malone, and many others helped create over a 30-year period.

Malone, when reached by phone, said he was extremely busy, and unsure about giving an interview.

"I've gotten kind of wary of journalists for some reason," he said.

Suggested reads

  • 'We really did hit peak stupid': Elite investors on Wall Street say privately that the market is about to undergo a cataclysmic shift — and many won't survive the 'washout'

  • I went from working as a security guard and Amazon delivery helper to running my own web-design agency — and now make up to $57,000 a month

  • A couple bought an inaccessible strip of land on a Bali clifftop and spent 10 years building a multi-tiered villa on it. Take a look.
Click here to read this article on-site.

Read the stories that matter most to you from wherever you are with the Insider App. Download the app today!
Powered By SailthrU

Older messages

Save the Date: The Future of Ghost Kitchens

Thursday, March 3, 2022

Live event on March 10 at 1pm ET / 10am PT... INSIDER INSIDER The Future of Ghost Kitchens Register today for our live event on March 10 at 1pm ET / 10am PT Ghost kitchens are evolving rapidly, spurred

Warren Buffett's business empire hiked prices to offset soaring costs. Here are 9 Berkshire Hathaway companies that battled inflation in 2021.

Thursday, March 3, 2022

Buffett's sprawling conglomerate was hit by a winter storm, a yarn shortage, and a lack of warehouse workers and truck drivers last year. View in browser Business Insider Business Insider Business

Follow Insider’s coverage of Ukraine

Wednesday, March 2, 2022

We've been speaking with politicians, experts, and analysts about this crisis... INSIDER INSIDER Subscribe PHOTO CREDIT: Alan Chin for Insider Hi, my name is Jim Edwards, and I'm the editor in

I left a job I'd held for 16 years to become a stay-at-home dad. I never thought I'd do this, but it's been a blessing.

Wednesday, March 2, 2022

"I can always go back to work, but I'll never have this opportunity — to take care of my young children and my father — again," Zach Hefferen says. View in browser Business Insider

Russians are scrambling to withdraw US dollars at ATMs as the ruble hits a record low on sweeping Western sanctions

Tuesday, March 1, 2022

The ruble plunged nearly 30% against the US dollar on Monday to a fresh record low amid Western sanctions against Russia for its invasion of Ukraine. View in browser Business Insider Business Insider

You Might Also Like

Decisions Nobody Made

Friday, April 19, 2024

Dan Davies Introduces His New Book. Plus: Earnings Season! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Harry's Rant 4-19-24 Stocks Face Headwinds

Friday, April 19, 2024

image Harry's Rant April 19, 2024 Stocks seem to be facing headwinds due to bond yields. Is this creating a top? Harry Dent discusses the roles of market divergences, gold, and Bitcoin in

Do You Own Any Of These Stocks?

Friday, April 19, 2024

The following is a third-party sponsored message. It should not be considered a recommendation or endorsement by HS Dent Publishing. logo Book image ​ Fellow Investor Our proprietary research has

Blame it on the rent

Thursday, April 18, 2024

Bloomberg Evening Briefing View in browser Bloomberg When US inflation peaked above 7% back in 2022, the culprits were everywhere—spread across goods and services. Now, with inflation back below 3%,the

🇮🇳 It's all about India

Thursday, April 18, 2024

Chipmaker TSMC didn't have much to complain about | The US dollar has the world talking | Finimize TOGETHER WITH Hi Reader, here's what you need to know for April 19th in 3:14 minutes. 🪙

Home makeover on a budget? We have just the thing.

Thursday, April 18, 2024

Lower rates and potential value boost — get started. ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Mother Earth 🤝 Jane Fonda

Thursday, April 18, 2024

Plus, a new worksheet for stay-at-home moms. ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌ 

Visionary Valuations - Issue #464

Thursday, April 18, 2024

From AI enhancements to fintech revolutions, uncover the potential of next-generation financial technologies. April 18, 2024 FinTech Weekly cuts through the noise to bring you insights on how

Prepare for a Recession Unlike Any Other

Thursday, April 18, 2024

The following is a third-party sponsored message. It should not be considered a recommendation or endorsement by HS Dent Publishing. Exchange Dems Impose Shocking Law "401K-Funded Reparations?

Three facts about the rising number of UK business exits

Thursday, April 18, 2024

Jelle Barkema, Maren Froemel and Sophie Piton Record-high firm exits make headlines, but who are the firms going out of business? This post documents three facts about the rising number of corporations